<DOC>
	<DOCNO>NCT02152969</DOCNO>
	<brief_summary>To evaluate Drug-drug interaction</brief_summary>
	<brief_title>Drug-drug Interaction Study ( Telmisartan , Amlodipine , Chlorthalidone )</brief_title>
	<detailed_description>The purpose study evaluate Drug-Drug ( telmisartan , amlodipine and/ chlorthalidone ) interaction safety healthy adult volunteer .</detailed_description>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Participant body weight ≥55kg ( male ) ≥50kg ( female ) ideal body weight 80120 % ( ideal body weight ) 2. Who suffer clinically significant disease 3 . Provision sign write informed consent 1 . History clinically significant disease psychiatric , malignancy . 2 . A history drug abuse presence positive reaction drug abuse potential urine screening drug . 3 . Administration investigational product within 3 month prior first dose . 4 . Administration herbal medicine within 2 week administration ethical drug within 2 week administration overthecounter ( OTC ) drug within 1 week prior first dose investigational product ( investigator ( study doctor ) determine person meet criteria appropriately , relevant person may participate study ) . 5 . Volunteers consider eligible clinical trial investigator ( study doctor ) due reason include laboratory test result , ECGs , vital sign .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>